Regulations and compliance · Practical guide

GVP literature screening: from search strategy to documented case decision

A search log and hit count cannot tell you whether relevant safety information was recognised and followed up. For GVP literature monitoring, connect the search scope and results to screening and the subsequent decision. The example concerns EU marketing authorisation holders for human medicines.

Table of contents

At a glance

Which records make a GVP literature search traceable?

Record the search purpose, sources, complete strategy, restrictions actually used and execution date. Link results to documented screening and a justified decision for each relevant hit. Distinguish ICSR processing, further safety evaluation and justified exclusion. Check missing full texts, duplicates and the correct day zero. Where screening is outsourced, retain a traceable information path from the provider.

  • A search string and hit count alone do not constitute a complete review.
  • An article not required to be reported as an ICSR may remain relevant for safety evaluation.
  • Day Zero and accountability must not be deferred through service provider transfers.

1. Define the purpose of the search professionally and technically

Literature monitoring in human pharmaceutical pharmacovigilance serves more than the identification of completed individual case reports. GVP Module VI also includes information for ongoing safety assessments and periodic reports. Therefore, an article lacking a reportable individual case is not automatically insignificant.

The current definitions of ICH E2D(R1) should be considered in conjunction with the EU implementation strategy. Regional requirements remain relevant, for example, the at least weekly systematic literature review described in Module VI. This does not imply a general obligation to subscribe to every possible database. Selection must align with the product and information landscape.

Sources: [1] [2] [3]

2. Document such strategy including invisible boundaries

Document the database, interface, product and active ingredient terms, search syntax, and all applied filters. Some interfaces store language or publication type filters outside the visible search string. Without this information, it will not be possible to determine later why a relevant article did not appear in the results.

Module VI warns against inappropriate restrictions. Limiting searches to English-language publications or exclusively including only indexed case report forms may exclude relevant information. Additionally, verify date logic: a query should capture the intended newly added or updated data sets, not inadvertently retrieve only publications from the same calendar period.

Sources: [1]

3. Conduct the investigation as a continuous chain of evidence

Our own work matrix describes a specific workflow without prescribing a particular software. A small team can document these details in appropriate linked records. What is essential is that a reviewer can clearly understand both the search execution and subsequent case decision.

When modifying the search strategy, evaluate which hits will be additionally or no longer captured in the future. Known relevant publications may be used as test cases. However, the review of selected hits does not constitute proof that no relevant publications may be missing.

Own detection matrix for a literature search exercise
ComponentSpecific contentAssessment question
Literature search assignment Active ingredient, product reference, and intended use Are individual cases and additional safety information considered?
Execution Database, Syntax, Filters and Date Can the query that actually ran be reconstructed?
Period Date field used and coverage logic Have delayed or updated entries been included?
Initial review Quotation, Abstract and Decision Is the testing performed traceable and verifiable?
Further processing Classification, full-text requirement or evaluation task Is every relevant open hit visible?
Closure Process owners, open items, and controls Is the decision substantiated in content?

Sources: [1] [2]

4. Abstract, full text, and reporting decision differ

An abstract may already contain the essential minimum information. In such cases, the decision to initiate the deadline should not be deferred unconditionally until full text delivery. Conversely, a title containing a safety term does not automatically constitute a valid individual case report. Review the patient, source, suspected medicinal product, and the relevant medical facts within the specific regulatory context.

ICH E2D(R1) distinguishes among other things spontaneous observations and literature cases derived from studies. If a presumed relationship is not explicitly stated, the guideline requires a context-specific evaluation. Therefore, do not apply the simplified rule that only publications explicitly designated as causal should be reviewed. Document medical assessment and any missing information.

Sources: [1] [2]

5. Example: Twelve hits with different follow-up tasks

In the example run, twelve synthetic database hits are exported. Two of these represent duplicate references to the same publication, leaving ten distinct publications. This constitutes an initial deduplication at the publication level; additionally, whether multiple articles describe the same patient is further evaluated.

Two publications in the example contain sufficient individual case details. A third lacks critical information; it remains open with full-text or follow-up request. Two additional publications are directed to further safety evaluation. Five are explicitly excluded for specific reasons. The volumes assist in identifying missing tasks, not in replacing professional quality assessment with a simple percentage.

Example: completed hit register
Result groupCountDocumented expected result
Raw result 12 Export allocated to the run and strategy
Doubled Publication Citations 2 Linked to the respective remaining publications
ICSR Processing 2 Minimum criteria and Day Zero verified; case tasks opened
Clarification required 1 Missing information named; Responsible party and next action
Further safety assessment 2 Purpose of evaluation and handover documented
Justified Exclusion 5 Whenever a specific exclusion reason is provided
Reconciliation 10 different publications 2 + 1 + 2 + 5 = 10; open task remains visible

Sources: [1] [2]

6. Include external service providers and EMA monitoring appropriately

If the partner knows the minimum information earlier than your company, this earlier date is decisive; the receipt of his completed weekly report does not change the reporting period. GVP Module VI, Appendix 2.9 explicitly deals with collective reports: If the minimum information is already available in the abstract, the search date counts.

The EMA's Medical Literature Monitoring does not universally replace the comprehensive literature monitoring responsibilities of a marketing authorisation holder. The scope of coverage and the rules governing avoidance of duplicate submissions must be specifically considered. Document the tasks covered and the sources, products, or other evaluation purposes that remain within your procedure.

Sources: [1] [2]

7. Separate identification of content omissions and technical errors

Quality control should evaluate whether relevant publications have been identified and decisions have been made appropriately. Module VI recommends sampling of review assessments or selection decisions. Appendix 2.6 does not specify a fixed sample size. Establish a justified sample size and appropriate escalation procedures.

There are also technical questions: Was the search actually executed, exported completely and passed to the correct review inventory? A run with zero hits can be correct or based on a changed query. An empty result folder alone does not prove a successful zero hit run. Therefore, keep track of execution and result together.

Sources: [1]

8. Checklist for a traceable investigation closure

This internal checklist begins with the search request and concludes with open follow-up tasks. In the example, the third possible case publication must not be simply marked as completed, as all abstracts have been reviewed. The search can be considered closed while the technical clarification continues.

For small teams, a delegation policy is essential: open full-text records, time-critical case evaluations, and failed search runs must remain identifiable even during absence. When switching suppliers, particularly review previously documented decisions and the coverage of the transition period.

  • Justification for the product- and active ingredient-specific scope of search?
  • Syntax, filter, date logic, and source saved?
  • Has run and zero failure clearly been demonstrated?
  • Were the citations and available abstracts actually reviewed?
  • Were ICSR criteria and other safety relevance evaluated separately?
  • Is Day Zero derived from the correct knowledge timestamp?
  • Are publication duplicates and case duplicates distinguished?
  • Are open full-texts and inquiries with responsibility recipient available?

Sources: [1] [2]

Project experience and collaboration

Link the search run, the information available and the decision

With Pharmacovigilance, we follow a prepared literature search result through to a reasoned case decision. We examine which minimum information appeared in the abstract and when a contracted partner knew it. Internal searches may need a straightforward evidence trail. Several providers also need clear handovers and feedback. We check that search date, article acquisition and case assignment can be reconstructed later. Your designated experts make the reporting assessment.

Frequently asked questions about Pharmacovigilance literature searching

Is retaining the search string sufficient?

No. Supplement with database, date, and actually used restrictions. Some filters are not visible in the string view. Additionally, it must remain evident which results have been reviewed and how relevant hits have been further processed. The query alone does not constitute a decision.

Sources: [1]

Must searches be conducted exclusively by trade name?

No. Module VI mentions active substance search and relevant name variants. A pure trade name search may overlook publications lacking brand name indications. Justify the terms by product and database, rather than deriving the strategy solely from your current product name.

Sources: [1]

Are case report-indexed publications only relevant?

No. Individual case information may also be presented in other publication types. A corresponding limitation may exclude relevant information. Review the appropriateness of the search criteria and consider additional information for further safety evaluation.

Sources: [1]

May we only consider English-language texts?

A general limitation of the worldwide literature database to English-language publications is generally not appropriate according to module VI. The specific search and translation process must capture relevant information. Language barriers should be visible as an editing task.

Sources: [1]

Does Day Zero begin only with the complete article?

No. If the abstract already contains the minimum information, the search date is considered Day Zero (GVP Module VI, Appendix 2.7). If articles must be obtained first, the date on which the minimum information is actually available is used. Therefore, ensure timely full-text acquisition and document which information was known and when.

Sources: [1] [2]

Is an article without an ICSR automatically excluded?

No. It may be relevant for signal assessment or periodic safety reports. Therefore, separate the question regarding an individual adverse event from the broader safety relevance. Exclusion from a workstream must not unilaterally terminate the entire subsequent evaluation.

Sources: [1]

Does EMA monitoring fully replace our own search?

No. Verify its specific coverage and the relevant rules regarding submission. The EMA monitors selected literature for specific active substances. Other sources, products, and evaluation purposes may continue to remain within the responsibilities of the marketing authorization holder.

Sources: [1]

What applies if the service provider knew the result earlier?

Then, prior knowledge is attributed to the contracted partner. According to GVP Module VI, Appendix 2.9, the time period begins as soon as either your organization or the contract partner becomes aware of the minimum requirements, whichever occurs earlier. When minimum requirements are specified in the abstract, the search date is the decisive date for weekly searches, not the subsequent delivery of the consolidated report. Therefore, the search date, information status, and handover must remain clearly traceable.

Sources: [1] [2]

How do we indicate a run with no hits?

Maintain a traceable record of the performed search, including date, strategy, and results. Investigate unexpected no-result findings for potential technical or technical changes. The absence of files is not sufficient evidence that the search did not take place.

Sources: [1]

Do we need to perform each review completely twice?

No. GVP Module VI, Appendix 2.6 recommends quality checks on a sample of the reviews or article selection. A full double-check of every review is not intended. Establish appropriate controls, training, and escalation procedures and adjust the scope as specific errors or gaps become evident.

Sources: [1]

Sources and review date

Source date: 7 October 2026. GVP VI Rev. 2, in particular Appendix 2, together with ICH E2D(R1) and EU Implementation Strategy 2026. The example is an internal reference document.

  1. EMA: GVP Module VI – Collection, Processing, and Reporting of Suspected CasesRev. 2, July 28, 2017; applicable from November 22, 2017; VI.B.1.1.2; VI.C.2.2.3; Appendix 2 §§ 2.1–2.9, p. 12, 35, 93–97
  2. EMA/ICH: E2D(R1) – Post-approval safety dataStep 5, 18.09.2025; EU Efficacy 18.03.2026; § 4.2, p. 10–11; § 5.2, p. 18
  3. EMA: EU Implementation Strategy for ICH E2D(R1)EMA/11141/2026, 26.02.2026; PRAC 20.02.2026; § 2, S. 2: current EU transition and regional requirements

Sources checked: .

Daniel Herrmann, Daniel Herrmann Consulting

Daniel Herrmann Consulting

Literature hits up to the reasoned decision are pursued

We support you with proof-of-concept structures, service provider handovers, and review cases for search runs, hit reviews, and open follow-up tasks.

  • Computer system validation →

    Bring your GxP systems into validated operation, from laboratory software, MES and eQMS to ERP. We define the scope, plan risk-based tests using GAMP 5 and hand the evidence to QA for release.

Send a project enquiry Customer testimonials →